Ozempic, Wegovy, Mounjaro and Zepbound are the commercially available brand names of some of this class of drugs the two that have FDA approved indications for weight loss
But concerns are rising too Published The calls come thick and fast to Mumbai-based diabetologist Rahul Baxi - but not just from patients struggling to control blood sugar
She told the ABC her interest in the issue came after she was prescribed Mounjaro, a brand name for a prescription weight loss drug, in 2024
Benefits of GLP-1 and related therapies When prescribed and monitored by a doctor, these medicines may help patients achieve: Significant weight loss Improved blood-sugar control Reduced cardiovascular risk Lower blood pressure in some patients Improved metabolic health GLP-1 receptor agonists are already widely used for type 2 diabetes and weight management, and ongoing research suggests they may have benefits beyond these conditions

This chapter is set out as follows: History Clinical findings Images Management History Mucosal melanocytic macules are more common in women than men The age at onset is approximately 30 years Clinical findings Distribution The lips are the most common site, especially the central third of the lower lip Morphology Lesions present as brown-black macules, and are usually solitary - s everal lesions should increase the suspicion of a systemic condition such as Peutz-Jeghers syndrome, Addison's disease and multiple lentiginoses (eg the Leopard syndrome) Size - under 1 cm in diameter Once developed the lesions usually remain unchanged in size and colour Dermoscopic examination of oral and genital lesions Benign lesions - diffuse pigmentation with a peculiar parallel pattern of partially linear and partially curvilinear light-brown to dark-brown streaks Melanoma - the combination of blue, grey, or white colour with structureless zones are the strongest indicators of mucosal melanoma Clinical Images Please refer to notes on image rights at bottom of the page with regards to individual image ownership
